Delsia

Investors, Entrepreneurs Gather for Second Annual Autism Speaks Autism Investment Conference

San Francisco, Calif. (March 6, 2014) – This week, Autism Speaks welcomed more than 150 researchers, entrepreneurs, investors, biotech and pharmaceutical executives, healthcare professionals and autism-service providers to i... More...

Google Brings Entrepreneurial Boot Camp to Autism Investment Conference

This year’s Autism Investment Conference just became more exc... More...

Autism Speaks Hosts World’s First Autism Investment Conference

On February 21st, investors and product developers came together to discuss opportunities for addressing the autism community’s unmet needs

... More...

Arbaclofen Shows Promise for Treating Core Symptoms of Autism

Compound advances into larger clinical trials; could pave the way for other future medicines as well

... More...

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to ... More...

Contact Us

Address 85 Devonshire Street, 9th floor Boston, Massachusetts  02109 USA 617-726-1515

General information (contactus@delsia.org) Press/m... More...

Syndicate content